Telix Pharmaceuticals

ISIN AU000000TLX2

 | 

WKN A2H7JK

Market cap (in EUR)
5.114,85 Mio.
Country
Australien
Sector
Gesundheitswesen
Dividend yield
0,00%
 

Overview

Description

Telix Pharmaceuticals Limited. beschäftigt sich mit der Entwicklung und Vermarktung von verschiedenen Onkologieprodukten im klinischen Stadium. Das Unternehmen ist in den folgenden Segmenten tätig: Kommerziell, Produktentwicklung sowie Konzern und nicht zugeordnet. Das kommerzielle Segment umfasst den Verkauf von Illuccix und anderen Produkten nach Erhalt der behördlichen Zulassungen. Das Segment Produktentwicklung entwickelt radiopharmazeutische Produkte für die Vermarktung. Es konzentriert sich auf die Krebsbehandlung, insbesondere bei Prostata-, Nieren- und Glioblastom oder Hirntumoren. Zu seinen Produkten gehören TLX250, TLX591 und TLX101. Das Unternehmen wurde im November 2015 von Andreas Kluge und Christian P. Behrenbruch gegründet und hat seinen Hauptsitz in Melbourne, Australien.
Show more Show less
Gesundheitswesen Medizinische Geräte und Ausrüstung Andere medizinische Geräte Australien

Financials

Key metrics

Market capitalisation, EUR 5.114,85 Mio.
EPS, EUR -
P/B ratio 15,79
P/E ratio 177,84
Dividend yield 0,00%

Income statement (2024)

Revenue, EUR 477,80 Mio.
Net income, EUR 30,45 Mio.
Profit margin 6,37%

What ETF is Telix Pharmaceuticals in?

There are 16 ETFs which contain Telix Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Telix Pharmaceuticals is the Xtrackers S&P/ASX 200 UCITS ETF 1D.

Order fees

Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
 
Broker Rating Order fee Stock savings plans
0.99€
1000
View offer*
1.00€
2500
View offer*
0.00€
2500
View offer*
0.00€
1200
View offer*
0.00€
500
View offer*
Show all offers
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.

Savings plan offers

Here you can find information about the savings plan availability for the stock. You can use the table to compare savings plan offers for the selected savings rate.
 
Broker Rating Execution fee Account fee
0.00€
0.00€
View offer*
0.00€
0.00€
View offer*
1.50€
1.50%
0.00€
View offer*
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.